Medical Products Supplies Companies

Adenauerstr. 15, 52146 Würselen
Germany
Telephone +49 2405 4550-0
Fax +49 2405 4550-12
hemoteq@hemoteq.com
http://www.hemoteq.com

Product Categories

Product categories

01 Manufacturing of components
01.05 Surface treatment
01.05.03 Surface coating

Surface coating

03 Services
03.02 Consulting (services)
03.02.07 Medical device approval

Medical device approval

03 Services
03.04 Design and development
03.04.01 Product design, product development

Product design, product development

03 Services
03.05 Assembly

Assembly
Our products

Product category: Surface coating, Medical device approval, Product design, product development, Assembly
Coatings with controlled drug delivery
In DDCP, the drug coating is one of the key components that define clinical efficacy and safety of your unique combination product.

Our well-proven toolbox consists of various proprietary coating platforms and process know-how that can be applied, and customized, to virtually any device concept. These coatings reliably and precisely deliver a wide range of active pharmaceutical ingredients with a specified release profile that ensures optimal clinical performance.

We have extensive experience in customization and volume production of DDCP for the following applications:

• Drug-Eluting Stents

• Drug-Coated Balloons

• Drug Delivery Coatings of non-vascular implants

Product category: Surface coating, Medical device approval, Product design, product development, Assembly
Drug Coatings for Balloon Catheters
Drug-coated balloon (DCB) technology is opening up unforeseen options in vascular medicine. DCBs have become standard of care in peripheral vascular interventions and fpr the treatment of reoccluded coronary stents. We have achieved pioneering work when it comes to high-performance, low-dose balloon coatings by tailoring coating composition, excipient and process technology to optimally deliver the unique anti-restenotic drug Paclitaxel.

Many DCB concepts co-developed in collaboration with prestigious customers have been granted regulatory approval and are now successfully established in clinical routine.

In pursuit of the perfect DCB, new generations of balloon coatings have entered advanced-stage development, aiming at further optimizing DCB performance in challenging interventions and ultimately improving patients´ quality of life.

Product category: Surface coating, Medical device approval, Product design, product development, Assembly
Drug-Eluting Stent Coatings
Drug-eluting stents (DES) have revolutionized interventional cardiology and the treatment of patients suffering from coronary artery disease. Numerous OEMs are using Hemoteq´s coronary DES coating expertise for their innovative DES product range. Our unsurpassed range of DES platforms – polymer-based, polymer-free and excipient based drug releasing coatings – is the ideal launching pad for advanced DES addressing unmet needs in coronary and peripheral vascular interventions.

ad: contact information

About Us

Company details
Innovating together
Hemoteq is a leading contract development and contract manufacturing organisation (CDMO) for device drug combination products (DDCP) and specialty coated medical devices and components.

We have a proven track record backed by two decades of 360 degree expertise in advanced coating design, product and process development, regulatory strategy and volume production of DDCP and specialty coated components.

Working with Hemoteq headquartered in Würselen, Germany, you get access to the global capabilities of the Freudenberg Medical group – an „innovation hub“ that enables strategic innovation at the confluence of medtech, pharma and biotech.

Hemoteq operations work in accordance with applicable standards such as ISO 13485:2016.

ad: company